Exact Mass: 632.3322

Geissospermine

C40H48N4O3 (632.3726)

A indole alkaloid comprising two indole-derived polycyclic moieties joined by a cyclic ether linkage.

Phaeantharine

C39H40N2O6+2 (632.2886)

Coagulin R 3-glucoside

C34H48O11 (632.3196)

Coagulin R 3-glucoside is found in fruits. Coagulin R 3-glucoside is a constituent of Physalis peruviana (Cape gooseberry). Constituent of Physalis peruviana (Cape gooseberry). Coagulin R 3-glucoside is found in fruits.

Casokefamide

C33H40N6O7 (632.2958)

PA(8:0/PGE2)

C31H53O11P (632.3325)

PA(8:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGE2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/8:0)

C31H53O11P (632.3325)

PA(PGE2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/8:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/PGD2)

C31H53O11P (632.3325)

PA(8:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGD2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/8:0)

C31H53O11P (632.3325)

PA(PGD2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/8:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C31H53O11P (632.3325)

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0)

C31H53O11P (632.3325)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Myriceric acid A

C39H52O7 (632.3713)

Meliacarpinin B

C33H44O12 (632.2833)

Dichapetalin J

C39H52O7 (632.3713)

16alpha-Acetoxyasclepin

C33H44O12 (632.2833)

(+)-Kopsoffinol

C40H48N4O3 (632.3726)

Coagulin P

C34H48O11 (632.3196)

Dysinosin A

C26H44N6O10S (632.2839)

Longithorone E

C42H48O5 (632.3502)

3-p-Coumaroylactinidic acid

C39H52O7 (632.3713)

Tetrahydrogambogic acid

C38H48O8 (632.3349)

KBio2_000708

C38H48O8 (632.3349)

bugbanoside A

C35H52O10 (632.356)

Moritoside

C34H48O11 (632.3196)

trichilin G

C33H44O12 (632.2833)

aplysqualenol B

C31H53BrO8 (632.2924)

(5alpha,6alpha,7alpha,22R)-5-hydroxy-1,26-dioxo-6,7:22,26-diepoxyergosta-2,24-dien-27-yl beta-D-glucopyranoside|baimantuoluoside C

C34H48O11 (632.3196)

NSC333061

C33H44O12 (632.2833)

Myrtucommulone E

C38H48O8 (632.3349)

gomojoside I

C32H56O12 (632.3772)

MS000070186

C34H48O11 (632.3196)

C33H44O12

C33H44O12 (632.2833)

Methyl-alphitexolid

C39H52O7 (632.3713)

sitoindoside IX|sitoindoside-IX|sitoinoside IX

C34H48O11 (632.3196)

spinosyn alphac

C35H52O10 (632.356)

Euphoppin B

C34H48O11 (632.3196)

20-O-benzoyl-12-O-cinnamoyl-3beta,5alpha,8beta,12beta,14beta,17beta,20-heptahydroxy-(20S)-pregn-6-ene

C37H44O9 (632.2985)

petuniasterone I

C34H48O9S (632.3019)

Boussingoside C

C35H52O10 (632.356)

6,7,10-Triacetoxy-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-5a-(2-methylbutanoyloxymethyl)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

DTXSID90964460

C34H48O11 (632.3196)

6alpha-acetoxy-9beta-benzoyloxy-1beta-cinnamoyloxy-8beta-butanoyloxy-beta-dihydroagarofuran|6??-Acetoxy-9??-benzoyloxy-1??-cinnamoyloxy-8??-butanoyloxy-??-dihydroagarofuran

C37H44O9 (632.2985)

gomojoside D

C32H56O12 (632.3772)

C40H48N4O3

C40H48N4O3 (632.3726)

yuanhuajine

C37H44O9 (632.2985)

aphanalide D

C34H48O11 (632.3196)

beta-O-acetyl-spirost-5,25(27)-dien-3alpha-yl-O-beta-D-glucopyranoside|tupichinin B

C35H52O10 (632.356)

Vernonioside A1

C35H52O10 (632.356)

aphanalide E

C34H48O11 (632.3196)

aphanagranin D

C33H44O12 (632.2833)

Vernonioside B1

C35H52O10 (632.356)

aphanalide C

C34H48O11 (632.3196)

walsogyne E

C34H48O11 (632.3196)

3R/S-hydroxytabernamine

C40H48N4O3 (632.3726)

C35H52O10

C35H52O10 (632.356)

NCI60_039302

C34H48O11 (632.3196)

20,27-dihydroxy-3beta-(O-beta-D-glucopyranosyl)-1-oxo-(20S,22R)-witha-5,14,24-trienolide|coagulin P

C34H48O11 (632.3196)

C39H52O7

C39H52O7 (632.3713)

(20S,22R,25S)-furostan-22,25-epoxy-2alpha,3beta,6beta,26-tetraol tetraacetate

C35H52O10 (632.356)

7,10-Diacetoxy-5a-(acetoxymethyl)-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-6-(2-methylbutanoyloxy)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

6,10-Diacetoxy-5a-(acetoxymethyl)-5-(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-4-(2-methylbutanoyloxy)-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9-ol

C33H44O12 (632.2833)

MS000176795

C34H48O11 (632.3196)

dichapetalin C

C39H52O7 (632.3713)

(2R,5S,6S,7R,8R,9R,10S,12S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2,7-dihydroxy-6-[(2Z,4E)-decadienoyloxy]-12-hydroperoxycleroda-3,13(16),14-triene|argutin H

C34H48O11 (632.3196)

(2R,5S,6S,7R,8R,9R,10S,12S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2-[(2Z,4E)-decadienoyloxy]-6,7-dihydroxy-12-hydroperoxycleroda-3,13(16),14-triene|argutin G

C34H48O11 (632.3196)

benzyl 2-O-methylmicrophyllinate

C37H44O9 (632.2985)

ent-14-labden-8beta-ol 13alpha-O-beta-D-glucopyranosyl-19-O-alpha-L-rhamnopyranoside

C32H56O12 (632.3772)

Petuniasterone P3

C34H48O9S (632.3019)

Xyloccensin J

C33H44O12 (632.2833)

(3beta,5alpha,12beta,14beta,17alpha)-3-(beta-cymaropyranosyloxy)-8,14,17,20-tetrahydroxypregnan-12-yl benzoate

C35H52O10 (632.356)

myriceric acid A|Myriceric acid D

C39H52O7 (632.3713)

Methyl hexa(alpha-hydrocyisovalerate)

C31H52O13 (632.3408)

Petuniasterone P4

C34H48O9S (632.3019)

Tasumatrol F

C33H44O12 (632.2833)

A taxane diterpenoid isolated from Taxus sumatrana and has been shown to exhibit antineoplastic activity.

pfaffiaglycoside B

C35H52O10 (632.356)

Leu Ala Met Glu Arg

C26H48N8O8S (632.3316)

Goniomedine B

C40H48N4O3 (632.3726)

Tetrahydrogambogic Acid_major

C38H48O8 (632.3349)

Tetrahydrogambogic Acid_minor

C38H48O8 (632.3349)

Glu Ile Trp Trp

C33H40N6O7 (632.2958)

Glu Leu Trp Trp

C33H40N6O7 (632.2958)

Glu Trp Ile Trp

C33H40N6O7 (632.2958)

Glu Trp Leu Trp

C33H40N6O7 (632.2958)

Glu Trp Trp Ile

C33H40N6O7 (632.2958)

Glu Trp Trp Leu

C33H40N6O7 (632.2958)

His Lys Trp Tyr

C32H40N8O6 (632.3071)

His Lys Tyr Trp

C32H40N8O6 (632.3071)

His Trp Lys Tyr

C32H40N8O6 (632.3071)

His Trp Tyr Lys

C32H40N8O6 (632.3071)

His Tyr Lys Trp

C32H40N8O6 (632.3071)

His Tyr Trp Lys

C32H40N8O6 (632.3071)

Ile Glu Trp Trp

C33H40N6O7 (632.2958)

Ile Trp Glu Trp

C33H40N6O7 (632.2958)

Ile Trp Trp Glu

C33H40N6O7 (632.2958)

Lys His Trp Tyr

C32H40N8O6 (632.3071)

Lys His Tyr Trp

C32H40N8O6 (632.3071)

Lys Asn Trp Trp

C32H40N8O6 (632.3071)

Lys Trp His Tyr

C32H40N8O6 (632.3071)

Lys Trp Asn Trp

C32H40N8O6 (632.3071)

Lys Trp Trp Asn

C32H40N8O6 (632.3071)

Lys Trp Tyr His

C32H40N8O6 (632.3071)

Lys Tyr His Trp

C32H40N8O6 (632.3071)

Lys Tyr Trp His

C32H40N8O6 (632.3071)

Leu Glu Trp Trp

C33H40N6O7 (632.2958)

Leu Trp Glu Trp

C33H40N6O7 (632.2958)

Leu Trp Trp Glu

C33H40N6O7 (632.2958)

Asn Lys Trp Trp

C32H40N8O6 (632.3071)

Asn Trp Lys Trp

C32H40N8O6 (632.3071)

Asn Trp Trp Lys

C32H40N8O6 (632.3071)

Trp Glu Ile Trp

C33H40N6O7 (632.2958)

Trp Glu Leu Trp

C33H40N6O7 (632.2958)

Trp Glu Trp Ile

C33H40N6O7 (632.2958)

Trp Glu Trp Leu

C33H40N6O7 (632.2958)

Trp His Lys Tyr

C32H40N8O6 (632.3071)

Trp His Tyr Lys

C32H40N8O6 (632.3071)

Trp Ile Glu Trp

C33H40N6O7 (632.2958)

Trp Ile Trp Glu

C33H40N6O7 (632.2958)

Trp Lys His Tyr

C32H40N8O6 (632.3071)

Trp Lys Asn Trp

C32H40N8O6 (632.3071)

Trp Lys Trp Asn

C32H40N8O6 (632.3071)

Trp Lys Tyr His

C32H40N8O6 (632.3071)

Trp Leu Glu Trp

C33H40N6O7 (632.2958)

Trp Leu Trp Glu

C33H40N6O7 (632.2958)

Trp Asn Lys Trp

C32H40N8O6 (632.3071)

Trp Asn Trp Lys

C32H40N8O6 (632.3071)

Trp Trp Glu Ile

C33H40N6O7 (632.2958)

Trp Trp Glu Leu

C33H40N6O7 (632.2958)

Trp Trp Ile Glu

C33H40N6O7 (632.2958)

Trp Trp Lys Asn

C32H40N8O6 (632.3071)

Trp Trp Leu Glu

C33H40N6O7 (632.2958)

Trp Trp Asn Lys

C32H40N8O6 (632.3071)

Trp Tyr His Lys

C32H40N8O6 (632.3071)

Trp Tyr Lys His

C32H40N8O6 (632.3071)

Tyr His Lys Trp

C32H40N8O6 (632.3071)

Tyr His Trp Lys

C32H40N8O6 (632.3071)

Tyr Lys His Trp

C32H40N8O6 (632.3071)

Tyr Lys Trp His

C32H40N8O6 (632.3071)

Tyr Trp His Lys

C32H40N8O6 (632.3071)

Tyr Trp Lys His

C32H40N8O6 (632.3071)

RESLE

C25H44N8O11 (632.3129)

16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester

C37H48N2O7 (632.3461)

Coagulin R 3-glucoside

C34H48O11 (632.3196)

cuscutic resinoside A

C32H56O12 (632.3772)

3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[ 5.5]undecane (PEP-36)

C35H54O6P2 (632.3395)

(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate

C34H49F5O3S (632.3322)

Locicortolone

C36H50Cl2O5 (632.3035)

tris(2,5,8,11-tetraoxatridecyl) orthoborate

C27H57BO15 (632.379)

[D-Ala2,4,Tyr5] -b-Casomorphin (1-5)

C33H40N6O7 (632.2958)

Methyl propionate-PEG12

C28H56O15 (632.3619)

Sitoindoside IX

C34H48O11 (632.3196)

A withanolide saponin that consists of withaferin A attached to a beta-D-glucopyranosyl residue at position 27 via a glycosidic linkage. Isolated from Physalis longifolia, it exhibits antineoplastic activity.

Ajugamarin H1

C34H48O11 (632.3196)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

ajugamarin G1

C34H48O11 (632.3196)

A diterpene lactone isolated from the whole plant of Ajuga ciliata.

PA(8:0/PGE2)

C31H53O11P (632.3325)

PA(PGE2/8:0)

C31H53O11P (632.3325)

PA(8:0/PGD2)

C31H53O11P (632.3325)

PA(PGD2/8:0)

C31H53O11P (632.3325)

PA(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C31H53O11P (632.3325)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0)

C31H53O11P (632.3325)

2-[[(2R)-3-acetyloxy-2-[(5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H51NO11P+ (632.32)

2-[[(2R)-2-acetyloxy-3-[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H51NO11P+ (632.32)

Dinoxin B

C34H48O11 (632.3196)

A natural product found in Datura inoxia.

[4-[(4-acetamidobenzoyl)amino]phenyl] (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4,4-dimethyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoate

C37H48N2O7 (632.3461)

3-O-trans-p-coumaroyl actinidic acid

C39H52O7 (632.3713)

A pentacyclic triterpenoid that is the cinnamate ester obtained by the formal condensation of the carboxy group of trans-4-coumaric acid with the hydroxy group at position 3 of actinidic acid (the 2alpha,3beta stereoisomer). It is isolated from the roots of Actinidia arguta and exhibits inhibitory activity towards pancreatic lipase.

Argutin H

C34H48O11 (632.3196)

A natural product found in Casearia arguta.

Argutin G

C34H48O11 (632.3196)

A natural product found in Casearia arguta.

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C36H48N4O6 (632.3574)

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-9-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C36H48N4O6 (632.3574)

methyl (1S,13R,22S,23R,26E,27R,28S)-13-ethyl-26-ethylidene-21-oxa-9,17,24,29-tetrazadecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.022,29.030,35]nonatriaconta-3,5(18),6(16),19,30,32,34-heptaene-28-carboxylate

C40H48N4O3 (632.3726)

methyl (2R)-2-[(2R,3Z,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-2-[(1R,9S,12S,13S,14S,19S,21S)-14-ethyl-10-oxa-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6-trien-9-yl]acetate

C40H48N4O3 (632.3726)

methyl (1S,13R,22S,23S,26E,27S)-13-ethyl-26-ethylidene-21-oxa-9,17,24,29-tetrazadecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.022,29.030,35]nonatriaconta-3,5(18),6(16),19,30,32,34-heptaene-28-carboxylate

C40H48N4O3 (632.3726)

Smgdg O-18:5_3:0

C30H48O12S (632.2866)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C32H57O10P (632.3689)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C32H57O10P (632.3689)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C32H57O10P (632.3689)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C32H57O10P (632.3689)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C32H57O10P (632.3689)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C32H57O10P (632.3689)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C32H57O10P (632.3689)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C35H53O8P (632.3478)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C32H57O10P (632.3689)

[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C35H52O10 (632.356)

[1-[(E)-dec-4-enoyl]oxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C32H57O10P (632.3689)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H53O8P (632.3478)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C35H53O8P (632.3478)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H53O8P (632.3478)

[1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C32H57O10P (632.3689)

SMGDG O-21:5

C30H48O12S (632.2866)

SQDG 21:4

C30H48O12S (632.2866)

DGMG 15:4

C30H48O14 (632.3044)

SQMG 22:4

C31H52O11S (632.323)

DGGA 23:1;O

C32H56O12 (632.3772)

DGGA 25:7

C34H48O11 (632.3196)

MGGA 26:7

C35H52O10 (632.356)

PA O-29:4;O3

C32H57O10P (632.3689)

PA P-18:0/11:3;O3

C32H57O10P (632.3689)

PA 16:0/13:3;O2

C32H57O10P (632.3689)

PA 16:1/12:3;O3

C31H53O11P (632.3325)

PA 20:1/8:3;O3

C31H53O11P (632.3325)

PA 20:2/8:2;O3

C31H53O11P (632.3325)

PA 20:2/9:1;O2

C32H57O10P (632.3689)

PA 22:0/7:3;O2

C32H57O10P (632.3689)

PA 22:1/7:2;O2

C32H57O10P (632.3689)

PA 28:4;O3

C31H53O11P (632.3325)

PA 29:3;O2

C32H57O10P (632.3689)

PA 32:8

C35H53O8P (632.3478)

LPGP O-22:1

C28H58O11P2 (632.3454)

LPGP P-22:0

C28H58O11P2 (632.3454)

PG O-25:5;O2

C31H53O11P (632.3325)

PG O-26:4;O

C32H57O10P (632.3689)

PG P-16:0/9:4;O2

C31H53O11P (632.3325)

PG P-18:0/8:3;O

C32H57O10P (632.3689)

PG P-18:1/7:3;O2

C31H53O11P (632.3325)

PG P-18:1/8:2;O

C32H57O10P (632.3689)

PG P-20:1/6:2;O

C32H57O10P (632.3689)

PG 18:1/7:3;O

C31H53O11P (632.3325)

PG 20:3/5:1;O

C31H53O11P (632.3325)

PG 20:4/4:1;O2

C30H49O12P (632.2961)

PG 24:5;O2

C30H49O12P (632.2961)

PG 25:4;O

C31H53O11P (632.3325)

PG 22:2/4:1

C32H57O10P (632.3689)

PG 26:3

C32H57O10P (632.3689)

PG 4:0_22:3

C32H57O10P (632.3689)

PEth 30:8

C35H53O8P (632.3478)

PM 31:8

C35H53O8P (632.3478)

ST 24:1;O8;GlcA

C30H48O14 (632.3044)

ST 25:0;O7;GlcA

C31H52O13 (632.3408)

ST 27:6;O6;GlcA

C33H44O12 (632.2833)

ST 28:5;O5;GlcA

C34H48O11 (632.3196)

ST 29:4;O4;GlcA

C35H52O10 (632.356)

ST 25:1;O8;Hex

C31H52O13 (632.3408)

ST 26:0;O7;Hex

C32H56O12 (632.3772)

ST 27:7;O7;Hex

C33H44O12 (632.2833)

ST 28:6;O6;Hex

C34H48O11 (632.3196)

ST 29:5;O5;Hex

C35H52O10 (632.356)

14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C33H44O12 (632.2833)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-{2-[(2-methylbutanoyl)oxy]-2-(5-oxo-2h-furan-3-yl)ethyl}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbut-2-enoate

C34H48O11 (632.3196)

(6r,14r)-13-hydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H48O8 (632.3349)

methyl (1r,9r,16r,18r,21s)-6-[(15r,17r,19s)-15-[(1r)-1-hydroxyethyl]-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O3 (632.3726)

methyl (1s,12r,14s,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C40H48N4O3 (632.3726)

(1s,2r,4r,5r,6s,8r,10s,11s,12r,14r,15s,19r,20r,21s)-20-(acetyloxy)-6-(furan-3-yl)-4,12,19,21-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-5-ylmethyl acetate

C35H52O10 (632.356)

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-5-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,3s,4s,5r,6r,7r)-1-[(3e)-3,5-dimethyl-6-phenylhex-3-en-1-yl]-6-{[(2e,4s,6s)-4,6-dimethyloct-2-enoyl]oxy}-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C33H44O12 (632.2833)

(3s,6s,9s,12s)-3-benzyl-9-{[4-(buta-2,3-dien-1-yloxy)-3-hydroxyphenyl]methyl}-5,11-dihydroxy-1,7-dimethyl-6,12-bis(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C36H48N4O6 (632.3574)

12-deacetyltrichilin i

C33H44O12 (632.2833)

{"Ingredient_id": "HBIN000775","Ingredient_name": "12-deacetyltrichilin i","Alias": "NA","Ingredient_formula": "C33H44O12","Ingredient_Smile": "NA","Ingredient_weight": "632.703","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9367","PubChem_id": "NA","DrugBank_id": "NA"}

1-deoxy-11-methoxy-3- tigloyloxymeliacarpinin

C33H44O12 (632.2833)

{"Ingredient_id": "HBIN002474","Ingredient_name": "1-deoxy-11-methoxy-3- tigloyloxymeliacarpinin","Alias": "NA","Ingredient_formula": "C33H44O12","Ingredient_Smile": "NA","Ingredient_weight": "632.703","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9220","PubChem_id": "NA","DrugBank_id": "NA"}

6α-acetoxy-9β-benzoyloxy-1β-cinnamoyloxy-8β-butanoyloxy-β-dihydroagarofuran

C37H44O9 (632.2985)

{"Ingredient_id": "HBIN012195","Ingredient_name": "6\u03b1-acetoxy-9\u03b2-benzoyloxy-1\u03b2-cinnamoyloxy-8\u03b2-butanoyloxy-\u03b2-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C37H44O9","Ingredient_Smile": "CCCC(=O)OC1C2C(C3(C(CCC(C3(C1OC(=O)C4=CC=CC=C4)C)OC(=O)C=CC5=CC=CC=C5)C)OC2(C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "131","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6″-O-trans-sinapoylgenipin gentiobioside

C34H48O11 (632.3196)

{"Ingredient_id": "HBIN012724","Ingredient_name": "6\u2033-O-trans-sinapoylgenipin gentiobioside","Alias": "NA","Ingredient_formula": "C34H48O11","Ingredient_Smile": "CC1C(C(C(OC1COC2C(C(C(C(O2)CO)O)O)O)OC(=O)C(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=O)C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40184","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,4r,5s,6r,8r,10s,11s,12s,14r,15r,16s,19r,20s,21r)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl (2r)-2-methylbutanoate

C33H44O12 (632.2833)

(2r,3r,4r,5r,6s)-2-{[(1r,4ar,5s,6r,8as)-6-hydroxy-1,4a,6-trimethyl-5-[(3s)-3-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-4-en-1-yl]-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

C32H56O12 (632.3772)

(6r)-6-[(1r)-1-[(1s,3br,7s,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,5h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

4,5,12-tris(acetyloxy)-2-hydroxy-2,10,10-trimethyl-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2e,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

methyl (1r,9r,16s,18r,21s)-6-[(15r,17r,19s)-15-(1-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O3 (632.3726)

[3,4-bis(acetyloxy)-5-hydroxy-6-[4-hydroxy-5-methyl-2-(3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl)phenoxy]oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2s)-2-{[(2s)-2-methylbutanoyl]oxy}-2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

[3,4-bis(acetyloxy)-5-hydroxy-6-[4-hydroxy-2-(9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5-methylphenoxy]oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(2r)-1-[(1s,2s,3'r,3as,3bs,4r,4'r,9ar,9br,11as)-4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-yl]-3-hydroxy-2,3-dimethylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1r,2r,3r,4s,5s,7r,8r,9r,10r,11s,13s,15r)-2,4-bis(acetyloxy)-8,16-dihydroxy-5,9,12,12-tetramethyl-7-{[(2e)-2-methylbut-2-enoyl]oxy}-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-15-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

[(2r,3s,4r,5r,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9r)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(2s,3r,5r)-5-[(1r)-1-[(2s,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-hydroxyethyl]-2-[(3r)-5-hydroxy-3-methoxy-4-methylidenepentyl]-2-methyloxolan-3-ol

C31H53BrO8 (632.2924)

(2s,3s,4r,5s,6r)-5-(acetyloxy)-6-{[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-18-hydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl acetate

C34H48O11 (632.3196)

methyl 2-{14-ethyl-10-oxa-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6-trien-9-yl}-2-{3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}acetate

C40H48N4O3 (632.3726)

(1s)-2-[(4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-{[(2s)-2-methylbutanoyl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

6-[1-(9a,11a-dimethyl-9-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

6-hydroxy-2,16-dimethyl-15-{1-[4-methyl-6-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one

C34H48O11 (632.3196)

3-[4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-ylmethyl]-3-hydroxy-2-methylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

[3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9s)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(3r)-3-[(1s,2s,3'r,3as,3bs,4r,4'r,9ar,9bs,11as)-4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-ylmethyl]-3-hydroxy-2-methylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

6,8-bis(acetyloxy)-5-[(acetyloxy)methyl]-2,4,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-2h,3h,4h,4ah,5h,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl benzoate

C33H44O12 (632.2833)

(6r)-6-[(1r)-1-[(1s,3br,7r,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H48O11 (632.3196)

4-({5-[(2-{[5-({3-[(5-aminopentyl)(hydroxy)carbamoyl]-1-hydroxypropylidene}amino)pentyl]-c-hydroxycarbonimidoyl}ethyl)(hydroxy)carbamoyl]pentyl}(hydroxy)carbamoyl)butanoic acid

C28H52N6O10 (632.3745)

4-[(benzyloxy)carbonyl]-3-methoxy-5-(2-oxoheptyl)phenyl 2-hydroxy-4-methoxy-6-(2-oxoheptyl)benzoate

C37H44O9 (632.2985)

[3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl]phenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

methyl 7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-[(2-methylbut-2-enoyl)oxy]-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-5-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C37H44O9 (632.2985)

3-(9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl)-4-hydroxy-5-(2-isopropyl-3-methyloxiran-2-yl)oxolan-2-one

C35H52O10 (632.356)

(1s,2s,4s,5r,10r,11s,14r,15r,18s)-5-hydroxy-10,14-dimethyl-15-[(1s)-1-[(2r)-4-methyl-6-oxo-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl]-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C34H48O11 (632.3196)

(1s)-2-[(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)

(1s,2r,4r,5r,6s,8r,10s,11s,12r,14r,15s,19r,20r,21s)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-8-[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

methyl 8,12,18-tris(acetyloxy)-6-(furan-3-yl)-9,14-dihydroxy-1,7,11,15-tetramethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C33H44O12 (632.2833)

12-(acetyloxy)-8-(butanoyloxy)-2,6,10,10-tetramethyl-5-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C37H44O9 (632.2985)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2z,4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

1,3-bis(acetyloxy)-7-(2-hydroperoxy-3-methylidenepent-4-en-1-yl)-5,9-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl deca-2,4-dienoate

C34H48O11 (632.3196)

5-hydroxy-10,14-dimethyl-15-{1-[4-methyl-6-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl}-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C34H48O11 (632.3196)

5-(acetyloxy)-6-{[18-hydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-7-yl]oxy}-4-methoxy-2-methyloxan-3-yl acetate

C34H48O11 (632.3196)

(3e,10e,26z)-4,11,27-trimethyl-17,31,33,35-tetraoxo-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(32),3,10,15,18,23(34),26,29-octaene-7-carbaldehyde

C42H48O5 (632.3502)

(3r,5s)-3-[(1r,2r,3ar,5as,7s,9as,11as)-2-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-[(2r,3s)-2-isopropyl-3-methyloxiran-2-yl]oxolan-2-one

C35H52O10 (632.356)

methyl 10-(4-methoxybenzoyloxy)-4,5,9,9,12-pentamethyl-20-oxo-18-(prop-1-en-2-yl)-19-oxahexacyclo[16.2.2.0¹,¹⁷.0⁴,¹⁶.0⁵,¹³.0⁸,¹²]docosane-11-carboxylate

C39H52O7 (632.3713)

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

(1s,2r,6r,8r,10r,11s,12s,15r,16s)-15-hydroxy-2,16-dimethyl-5-oxo-15-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

(2s,3s,4s,5r,6r)-6-{[(3s,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4-(hydroxymethyl)-4,6a,6b,14b-tetramethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H52O10 (632.356)

(2s,3r,4s,5r)-2-[(1r,1's,2r,4'r,5s,5'r,6'r,10's,12'r,16's,18's,20's,21's)-4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-13'-ene-4,20'-dioloxy]oxane-3,4,5-triol

C35H52O10 (632.356)

(4as,6ar,6br,8ar,12ar,12br,14bs)-6a-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

C39H52O7 (632.3713)

(3e,6s,7s,10e,14s,21r,26z)-4,11,27-trimethyl-17,31,33,35-tetraoxo-14-(prop-1-en-2-yl)pentacyclo[27.2.2.1⁶,²³.1¹⁵,¹⁹.0⁷,²¹]pentatriaconta-1(32),3,10,15,18,23(34),26,29-octaene-7-carbaldehyde

C42H48O5 (632.3502)

n-[(2s)-1-oxo-1-{[(8z,10z,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]benzenecarboximidic acid

C36H44N2O8 (632.3098)

methyl (1r,4r,5r,8s,10s,11s,12r,13r,16r,17r,18s)-10-(4-methoxybenzoyloxy)-4,5,9,9,12-pentamethyl-20-oxo-18-(prop-1-en-2-yl)-19-oxahexacyclo[16.2.2.0¹,¹⁷.0⁴,¹⁶.0⁵,¹³.0⁸,¹²]docosane-11-carboxylate

C39H52O7 (632.3713)

(1s,3s,5s,7r,9r,10s,12s,14s,15r,18s,19s,20s,22r,23r)-9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

3-(2-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl)-5-(2-isopropyl-3-methyloxiran-2-yl)oxolan-2-one

C35H52O10 (632.356)

(1s,2r,4s,5r,6s,8r,10s,11s,12r,14r,15r,16r,19r,20r,21s)-21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl (2r)-2-methylbutanoate

C33H44O12 (632.2833)

1,3-bis(acetyloxy)-7-(2-hydroperoxy-3-methylidenepent-4-en-1-yl)-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl deca-2,4-dienoate

C34H48O11 (632.3196)

2-[8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-4-[(2-methylbutanoyl)oxy]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(5-oxo-2h-furan-3-yl)ethyl 2-methylbut-2-enoate

C34H48O11 (632.3196)

[(2r,3s,4r,5r,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyl-9-oxododeca-2,6-dien-1-yl]phenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

1-[4-(acetyloxy)-2-hydroxy-3',9a,11a-trimethyl-7-oxo-3,3a,3b,4,5,9b,10,11-octahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxetan]-4'-yl]-3-hydroxy-2,3-dimethylbutan-2-yl 3-(methylsulfanyl)-3-oxopropanoate

C34H48O9S (632.3019)

methyl 6,7-dihydroxy-2-[(1s,2r,3r,5r,6r,9s,14s,15r,18s)-3-hydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docosa-11,16-dien-19-yl]-6-methyl-4-oxoheptanoate

C39H52O7 (632.3713)

(3s,5r)-3-[(1r,2r,3r,5r,6r,9s,14s,15r,17r,18s,19s)-3,17-dihydroxy-9-(4-methoxyphenyl)-2,6,14-trimethyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]oxolan-2-one

C39H52O7 (632.3713)

methyl 6-[15-(1-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O3 (632.3726)

(1s,2s,4s,5r,6r,7s,9r,12r)-4,5,12-tris(acetyloxy)-2-hydroxy-2,10,10-trimethyl-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H44O12 (632.2833)

9-(acetyloxy)-14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-20-yl acetate

C33H44O12 (632.2833)

(3s,4r,5s)-3-[(1r,3ar,5as,7s,9as,11ar)-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-5-[(2r,3s)-2-isopropyl-3-methyloxiran-2-yl]oxolan-2-one

C35H52O10 (632.356)

methyl (1r,9r,16r,18r,21s)-6-[(15s,17s,19r)-15-[(1r)-1-hydroxyethyl]-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O3 (632.3726)

5-{1-[6-(5-bromo-2,6,6-trimethyloxan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-hydroxyethyl}-2-(5-hydroxy-3-methoxy-4-methylidenepentyl)-2-methyloxolan-3-ol

C31H53BrO8 (632.2924)

15-hydroxy-2,16-dimethyl-5-oxo-15-(1-{5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

(4s)-4-[(2r,4ar,6r)-6-(5-bromo-2,6,6-trimethyloxan-2-yl)-4a,6,8a-trimethyl-tetrahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentane-1,4-diol

C32H57BrO7 (632.3287)

1-(3,5-dimethyl-6-phenylhex-3-en-1-yl)-6-[(4,6-dimethyloct-2-enoyl)oxy]-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C33H44O12 (632.2833)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C33H44O12 (632.2833)

(1s,3r,6s,8r,12r,13r,15r,16r,18s)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-13,18-dihydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O10 (632.356)

(2s,3r,4s,5r)-2-[2-(6-chlorododecyl)-5-(7-chloroundecyl)-3-hydroxyphenoxy]oxane-3,4,5-triol

C34H58Cl2O6 (632.361)

(1r,2r,7r,10r,11s,14r,15s,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadec-4-en-9-one

C34H48O11 (632.3196)

(1s,2r,6r,8r,10r,11s,12s,15r,16s)-15-hydroxy-2,16-dimethyl-5-oxo-15-[(1r)-1-[(3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-3-en-10-yl acetate

C34H48O9S (632.3019)

methyl (1r,4s,5r,6s,7r,8s,10r,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

6-{[8a-carboxy-4-(hydroxymethyl)-4,6a,6b,14b-tetramethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H52O10 (632.356)

(1s,3r,5r,6as,7s,8s,9r,10s,10as)-1,3-bis(acetyloxy)-7-[(2r)-2-hydroperoxy-3-methylidenepent-4-en-1-yl]-9,10-dihydroxy-7,8-dimethyl-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (4e)-deca-2,4-dienoate

C34H48O11 (632.3196)

methyl (1s,2r,4s,6s,7r,8r,9r,10r,11s,12s,14r,15s,16r,18r)-8,12,18-tris(acetyloxy)-6-(furan-3-yl)-9,14-dihydroxy-1,7,11,15-tetramethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C33H44O12 (632.2833)

[(2r,3r,4s,5s,6r)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9s)-9-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C34H48O11 (632.3196)

methyl (1r,4s,5r,6s,7r,8s,10s,14s,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

13-hydroxy-9-(3-hydroxybut-1-en-1-yl)-14-methyl-2-[(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy]-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C35H52O10 (632.356)

21-(acetyloxy)-6-(furan-3-yl)-4,12,19,20-tetrahydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate

C33H44O12 (632.2833)

2-{[6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

C32H56O12 (632.3772)

15-[4-(3,3-dimethyloxiran-2-yl)-4-oxobutan-2-yl]-13,18-dihydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O10 (632.356)

methyl (1r,4s,5r,6s,7r,8s,10r,14r,15s,16r,18s,19r,22r,23r,26r)-7,14-dihydroxy-4-methoxy-6,16,22-trimethyl-23-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9,11,17,20-pentaoxaoctacyclo[17.6.1.1⁸,¹⁵.0¹,⁵.0⁶,¹⁸.0⁷,¹⁶.0¹⁰,¹⁴.0²²,²⁶]heptacos-12-ene-4-carboxylate

C33H44O12 (632.2833)

13-hydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H48O8 (632.3349)

(1'r,2s,2's,4's,5s,7's,8'r,9's,12's,13'r,15'r,16'r,18's,19'r)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-5-ylmethyl acetate

C35H52O10 (632.356)

(2r)-n-[(2r)-1-[(2s,3ar,5s,6s,7as)-2-{[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethyl]carbamoyl}-5,6-dihydroxy-octahydroindol-1-yl]-4-methyl-1-oxopentan-2-yl]-2-methoxy-3-(sulfooxy)propanimidic acid

C26H44N6O10S (632.2839)

(3r,5s)-3-[(1r,2s,3ar,5as,7s,9as,11as)-2-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-[(2r,3s)-2-isopropyl-3-methyloxiran-2-yl]oxolan-2-one

C35H52O10 (632.356)

6a-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

C39H52O7 (632.3713)

3-benzyl-9-{[4-(buta-2,3-dien-1-yloxy)-3-hydroxyphenyl]methyl}-5,11-dihydroxy-1,7-dimethyl-6,12-bis(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C36H48N4O6 (632.3574)

(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-13-hydroxy-9-[(1e,3s)-3-hydroxybut-1-en-1-yl]-14-methyl-2-{[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C35H52O10 (632.356)

methyl (1s,12r,14s,15e,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C40H48N4O3 (632.3726)

(1r,4r,4ar,5s,6r,8s,8ar)-8-(acetyloxy)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2s)-2-{[(2r)-2-methylbutanoyl]oxy}-2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl (2e)-2-methylbut-2-enoate

C34H48O11 (632.3196)